Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1400
-0.0300 (-17.65%)
May 20, 2026, 3:20 PM EST
Lipella Pharmaceuticals Employees
As of December 31, 2024, Lipella Pharmaceuticals had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$64,964
Profits / Employee
-$888,293
Market Cap
646.46K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2023 | 7 | 0 | - | 5 | 2 |
| Dec 31, 2022 | 7 | 2 | 40.00% | 5 | 2 |
| Sep 30, 2022 | 5 | 0 | - | 4 | 1 |
| Jun 30, 2022 | 5 | - | - | 4 | 1 |
| Dec 31, 2021 | 5 | - | - | 4 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Emmaus Life Sciences | 33 |
| Evofem Biosciences | 29 |
| Windtree Therapeutics | 14 |
| Altamira Therapeutics | 11 |
| CERo Therapeutics Holdings | 8 |
| Avenue Therapeutics | 1 |
| CNBX Pharmaceuticals | 1 |
Lipella Pharmaceuticals News
- 7 weeks ago - Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11 - GlobeNewsWire
- 6 months ago - Lipella Pharmaceuticals Quarterly report: Q3 2025 - Filings
- 8 months ago - Lipella Pharmaceuticals Transcript: Life Sciences Virtual Investor Forum 2025 - Transcripts
- 8 months ago - Lipella Pharmaceuticals announces final results from Phase 2a study of LP-10 - TheFly
- 8 months ago - Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus - PRNewsWire
- 10 months ago - Lipella Pharmaceuticals Quarterly report: Q2 2025 - Filings
- 11 months ago - Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting - GlobeNewsWire
- 11 months ago - Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market - GlobeNewsWire